The growing demand for specific immunological research and therapeutic development has spurred significant improvements in recombinant signal molecule generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently produced using diverse expression platforms, including bacterial hosts, animal cell lines, and viral